We are live on ! Find out more
BNGO icon

Bionano Genomics

53 hedge funds and large institutions have $4.48M invested in Bionano Genomics in 2024 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 11 increasing their positions, 11 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

177% more call options, than puts

Call options by funds: $166K | Put options by funds: $60K

95% more capital inflows, than outflows

Capital inflows: $2.83M | Capital outflows: $1.45M

0.58% more ownership

Funds ownership: 8.98% → 9.56% (+0.58%)

0% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 14

0% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 11

2% less funds holding

Funds holding: 54 → 53 (-1)

Holders
53
Holders Change
-1
Holders Change %
-1.85%
% of All Funds
0.76%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
11
Reduced
11
Closed
14
Calls
$166​K
Puts
$60​K
Net Calls
+$106​K
Net Calls Change
-⁠$906​K

BNGO Hedge Fund Activity: Q2 2024 in Review

53 of the 6,945 institutional investors tracked by Wall St. Rank reported a position in Bionano Genomics (BNGO) for Q2 2024, worth a combined $4.48M — down 18% from $5.45M a quarter earlier.

Fund positioning in BNGO was balanced in Q2 2024: 14 funds opened new positions, 14 closed out, 11 added to existing stakes and 11 trimmed.

The largest buyer was Armistice Capital, opening a new position worth an estimated $1.54M. The largest seller was GSA Capital Partners, exiting entirely with an estimated $610K sold.

  • 53 institutional investors held Bionano Genomics (BNGO) as of Q2 2024, down from 54 in Q1 2024.
  • Funds reported $4.48M of Bionano Genomics stock for Q2 2024, down 18% quarter-over-quarter.
  • 14 funds opened new Bionano Genomics positions in Q2 2024 and 14 closed out, a net change of 0 holders.
  • The largest Bionano Genomics buyer in Q2 2024 was Armistice Capital, an estimated $1.54M added.
  • The largest Bionano Genomics seller in Q2 2024 was GSA Capital Partners, an estimated $610K sold.

Based on aggregated 13F filings for Q2 2024.